Respond to survey by November 13, 11:59 p.m. EST: www.surveymonkey.com/r/2022MIPSCostPC
In August, CMS released Merit-based Incentive Payment System (MIPS) performance feedback, final scores for the 2022 performance year, and associated MIPS payment adjustment information for the 2024 payment year. As APMA previously announced, podiatrists can view their 2022 MIPS performance feedback, including final scores and 2024 payment adjustment, by signing into the Quality Payment Program (QPP) website.
APMA has heard from several members that for the 2022 performance year, they received a score for the MIPS cost category. Specifically, members were scored on the diabetes episode-based cost measure, which in some cases negatively impacted their overall performance for 2022, which could reduce their Medicare payments in 2024.
APMA met with CMS yesterday to raise concerns about the inappropriate attribution of patients to podiatric practices under the Diabetes cost measure. APMA cited the fact that podiatric physicians are not treating the underlying cause of diabetes, but rather complications and symptoms that extend from diabetes (some of which may be costly). CMS has agreed to make adjustments to the measure’s attribution methodology that we believe will address this problem starting with the 2023 MIPS performance year. Unfortunately, options for recourse related to 2022 MIPS performance year scores are limited at this point in time. However, CMS has indicated that it would review the score calculations and potentially provide relief to any DPM who either reached out to the QPP Service Center since receiving their 2022 MIPS final score or submitted a formal Targeted Review request to CMS by the October 9, 2023 deadline.
In order to most expeditiously identify these members, and directly share their information with CMS, APMA asks that you respond to this survey by Monday, November 13, 2023.
For questions about this survey, or MIPS-related issues, please contact APMA at MIPS@apma.org.